Caterina Cecchetti

Busto Arsizio, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Site-specific biology of tongue base aggressive B-cell lymphomas revealed by molecular subtype classification.

Site-specific biology of tongue base aggressive B-cell lymphomas revealed by molecular subtype classification.

Journal: Haematologica

Published: March 16, 2026

Late-onset progressive multifocal leukoencephalopathy after teclistamab in multiple myeloma: extending the timeline of infectious risk.

Late-onset progressive multifocal leukoencephalopathy after teclistamab in multiple myeloma: extending the timeline of infectious risk.

Journal: Haematologica

Published: December 03, 2025

Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.

Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.

Journal: Leukemia & lymphoma

Published: January 11, 2025

Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma.

Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma.

Journal: Virchows Archiv : an international journal of pathology

Published: March 16, 2024

Gamma/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to "T-cell-receptor-silent" aggressive lymphoma: Description of one case.

Gamma/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to "T-cell-receptor-silent" aggressive lymphoma: Description of one case.

Journal: Journal of cutaneous pathology

Published: January 24, 2021

Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.

Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.

Journal: Hematological oncology

Published: March 10, 2020

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.

Journal: Blood advances

Published: January 07, 2020

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.

Journal: Blood

Published: December 21, 2018

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 23, 2017

Clarithromycin as a "repurposing drug" against MALT lymphoma.

Clarithromycin as a "repurposing drug" against MALT lymphoma.

Journal: British journal of haematology

Published: August 04, 2017

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.

Journal: The Lancet. Haematology

Published: November 11, 2016

Severe, reversible nelarabine-induced neuropathy and myelopathy.

Severe, reversible nelarabine-induced neuropathy and myelopathy.

Journal: Journal of the peripheral nervous system : JPNS

Published: November 30, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026